Govt officials likely to meet to discuss future course of Covid vaccination

7,072 beneficiaries vaccinated in six States on the second day of the vaccination drive.

To discuss the future course of COVID-19 vaccination efforts, the government officials likely to hold a meeting with representatives of pharmaceutical industries and other stakeholders on Monday.

According to a source, the government officials likely to hold a meeting with representatives of pharmaceutical industries along with other stakeholders to discuss the subsequent course of vaccination drive in the country.

Union Health Minister Harsh Vardhan on Sunday informed that over 2.24 lakh people vaccinated against COVID-19 till now. 17,072 beneficiaries vaccinated in six States on the second day of the vaccination drive.

"More than 2.24 lakh people vaccinated against COVID-19 till now. 17,072 beneficiaries vaccinated in 6 States on day 2. Three cases of post-vaccination hospitalisation reported. India vaccinates the highest number of persons on day 1 of the nationwide COVID-19 vaccination drive; more than many other countries," Vardhan said in a tweet.

Out of two lakh healthcare beneficiaries who received the COVID-19 vaccine in the last two days, a total of 447 beneficiaries suffered adverse events following immunisation (AEFI) while three of them required hospitalisation, the Union Health Ministry informed."A total of 447 adverse events following immunisation on 16th and 17th January out of which only three required hospitalisation," said Manohar Agnani, Additional Secretary at the Health Ministry."One has been discharged from the Northern Railway Hospital Delhi within 24 hours. One beneficiary has been discharged from AIIMS, New Delhi. While one beneficiary is under still observation in AIIMS, Rishikesh and is fine," said Agnani. Meeting with is being held with all States/Union Territories for review of progress to identify bottlenecks and planned corrective actions, said the Ministry.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel